2026³â 06¿ù 28ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 103598°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



LIG D&A-¶óÀθÞÅ», ÇÕÀÛȸ»ç ¼³¸³ ÃßÁø

À¯·´¡¤NATO ´ÙÃþ ¹æ°ø ü°è ±¸Ãà Çù·Â
LIG µðÆæ½º ¿¡¾î·Î½ºÆäÀ̽º(ÀÌÇÏ LIG D&A)¿Í ¶óÀθÞÅ» ¿¡¾îµðÆæ½º(ÀÌÇÏ ¶óÀθÞÅ»)°¡ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¸Î°í À¯·´ ¹× ³ªÅä(NATO)¿¡ ´ëÇÑ Ã·´Ü ¹æ°ø ½Ã½ºÅÛ °ø±ÞÀ» À§ÇØ Àü¹æÀ§Àû Çù·ÂÀ» ÃßÁøÇÑ´Ù. ¾ç»ç´Â À¯·´ ³» ´ÙÃþ ¹æ°ø ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ´Â »óȲ¿¡¼­ °í°´ ¿ä±¸¿¡ ºÎÇÕÇÏ´Â ÅëÇÕ ¹æ°ø ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇÑ Çù·Â ¹æ¾ÈÀ» ³íÀÇÇϰí ÀÖ´Ù. À̸¦ À§ÇÑ Ã¹ Çຸ·Î LIG¿Í ¶óÀθÞÅ» °£ÀÇ À¯·´ ³» ÇÕÀÛȸ»ç ¼³¸³°ú °ü·ÃÇÑ ³íÀǸ¦ ½Éµµ ÀÖ°Ô ÁøÇà ÁßÀÌ´Ù. À̹ø Çù·ÂÀ» ÅëÇØ ¾ç»ç´Â »óÈ£ º¸¿ÏÀûÀÎ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ±â¹ÝÀ¸·Î À¯·´ ...

¡®ÇÏÆ®½Ã±×³Î5¡¯ ÀÔÁÖÀÚ 8ÀÎ, ÀϺ» µµÄí½Ã¸¶·Î ¿©Çà ¶°³ª

¼³·½°ú ÁúÅõÀÇ ¼Ò¿ëµ¹ÀÌ ¿¹°í
‘ÇÏÆ®½Ã±×³Î5’ ÀÔÁÖÀÚ 8ÀÎÀÌ È¥µ·ÀÇ ·¯ºê¶óÀÎ ¼Ó ÀϺ» µµÄí½Ã¸¶·Î ¿©ÇàÀ» ¶°³­´Ù. 19ÀÏ(È­) ¹ã 10½Ã ¹æ¼ÛµÇ´Â ä³ÎA ‘ÇÏÆ®½Ã±×³Î5’(¿¬Ãâ ¹Úöȯ, ±èÈ«±¸) 6ȸ¿¡¼­´Â ‘½Ã±×³Î ÇϿ콺’ ÀÔÁÖÀÚ 8ÀÎ(¹Ú¿ì¿­-±è¼º¹Î-±è¼­¿ø-Á¤ÁØÇö-±è¹ÎÁÖ-Á¤±Ô¸®-°­À¯°æ-ÃÖ¼ÒÀ±)ÀÌ ÀϺ» µµÄí½Ã¸¶¿¡¼­ ¿©ÇàÀ» °âÇÑ µ¥ÀÌÆ®¸¦ ÇÏ¸ç º¹ÀâÇÑ °¨Á¤ÀÇ ¼Ò¿ëµ¹ÀÌ¿¡ ºüÁö´Â ¸ð½ÀÀÌ ´ã±ä´Ù. À̳¯ ÀϺ»¿¡ µµÂøÇÑ ÀÔÁÖÀÚµéÀº Â÷¸¦ Ÿ°í ¹Ù´å°¡·Î À̵¿ÇÑ´Ù. Â÷ ¾È¿¡¼­ °­À¯°æÀº ¹Ú¿ì¿­ÀÇ ¿·ÀÚ¸®¿¡ ¾É¾Æ ¹à°Ô ¿ô°í, Â÷°¡ Èçµé¸®ÀÚ ¹Ú ...

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its Firs...

Marks first launch in Japan through partnership with NIPRO CORPORATION.
INCHEON, KOREA -- Samsung Bioepis Co., Ltd. announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), marking its first product launch in Japan under partnership with NIPRO CORPORATION (hereafter “NIPRO”). The launch follows the Official Gazette announcement on May 19 regarding the product’s listing under the National Health Insurance (NHI) Drug Price Standard, which became effective tod ...
BCÄ«µå, 2023³â ¼Òºñ Ű¿öµå ¡®¸®¿ÀÇÁ´×¡¯ & ¡®°í¹°°¡¡¯ (2024-01-01)
LG Ç»¸®Äɾî 360µµ °ø±âûÁ¤±â 'Ŭ¸°ºÎ½ºÅÍ'·Î Àαâ (2017-04-14)
FEELM Organizes Giveaway Events to Support Vapril and Help S... (2023-04-28)
Arthur D. Little Appoints 9 New Partners Across Global Offic... (2024-10-27)
±¹¸³¼ö»ê°úÇпø, ÇØ»ï Á¤º¸ ¼­Àû Çѱ¹¾îÆÇ ¹ß°£ (2017-02-01)
È­¼º½Ã¹®È­Àç´Ü, ¾î¸°ÀÌ Ã¼ÇèÀü½Ã ¡®¹Ì¼ú°üÀÇ µ¿¹°¿ø¡¯ °³ÃÖ (2023-07-25)
RevBits Completes Development for its Privileged Access Mana... (2023-05-24)
±ÝȣŸÀ̾î-GS¿¡³ÊÁö, Àü±âÂ÷ ºÐ¾ß Çù·Â Àü·«Àû MOU (2023-11-03)
Áö¸à½º¿¡³ÊÁö, ±â°¡¿ÍÆ®±Þ ¼öÀüÇØ °øÀå ¼³¸³ (2023-11-29)
³²ºÏû¼Ò³âÁß¾Ó¿¬¸Í, 2024³â û¼Ò³â ÅëÀÏ´í½º °æ¿¬´ëȸ (2024-06-15)
No Charge, 6000 Puffs: ¡®Power Alpha¡¯ Breaks the Glass Ceil... (2023-06-22)
¼­Ãʱ¸, ã¾Æ°¡´Â û¼Ò³â µðÁöÅÐ ¼º¹üÁË ¿¹¹æ±³À° ½Ç½Ã (2024-04-27)
·Ôµ¥Ä«µå ¡®ÃæÀü ÇÊ¿ä ¾ø´Â ¿ëµ·Ä«µå¡¯ Ƽ´Ï Ä«µå Ãâ½Ã (2023-08-13)
Kenvue to Begin Trading on the New York Stock Exchange (2023-05-07)
3~5³âÂ÷ Á÷ÀåÀÎ 79.7% ¡®Áö±ÝÀÌ ÀÌÁ÷ ¿øÇÈ Å¸À̹֡¯ (2023-10-27)
÷´Ü¿£Áø ¼ÒÀç ±¹»êÈ­ À§ÇÑ ¡®Çù·Â »ýŰ衯 ±¸Ãà °­Á¶ (2023-11-09)
¹Ì¾²ÀÌÈ­ÇÐ, ¼¼°è ÃÖÃÊ·Î À¯¿¬ÇÑ °í°­µµ Á÷¹° °³¹ß (2017-05-27)
¾Ö°æÄɹÌÄ®, ±Û·Î¹ú Àç»ýÇ¥ÁØÀÎÁõ GRS ȹµæ (2023-09-21)
Black & Veatch Offering Insights to High-Level Presidential ... (2024-03-25)
°ø¿ø ǰÀº °í±ÞÀü¿øÁÖÅôÜÁö ¡®³²ÇѰ­Ä³½½¡¯ ºÐ¾ç (2023-06-28)
½º¸¶Æ®Æù¸¸ º¸´Â û¼Ò³â, ¸¶À½µ¹º½ÀÌ µ½´Â´Ù (2024-02-05)
UAE Commits Additional $6.26b in Industrial Offtakes (2024-06-08)
±¹³» ¼ÒºñÀÚ 58% ¡°ÇÏÀ̺¼ ¿­Ç³ ÃÖ¼Ò 2³â ÀÌ»ó Áö¼ÓµÉ °Í¡± (2023-12-31)
ÃæÁÖÅÃÁö°³¹ßÁö±¸ Àα٠ȣ¾Ï¿¹¼úÀθ¶À» Àü¿øÁÖÅà (2017-11-12)
New World Hotels and Resorts Unveils Accelerated Expansion P... (2023-09-01)
       [ÀÌÀü][1]....[1296][1297][1298][1299][1300][1301][1302][1303][1304]...[4144][´ÙÀ½]

°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..